In an effort to support micro-elimination efforts, the Gilead Medical Affairs team will support individual projects by providing grants of up to USD 350,000
Entries are now open for Gilead鈥檚 CHIME Program (Conquering Hepatitis C via Micro-Elimination) which focuses on supporting research into national and international hepatitis C elimination projects among smaller and more defined populations, known as micro-elimination of Hep C.
Gilead will support projects with research grants of up to USD 350,000 each, with an emphasis on achieving geographic distribution across the globe. Successful proposals will demonstrate clear scientific objectives, defined timelines, a comprehensive operational plan and the potential to generate data that has relevance to the medical community and policy makers.
Applicants are encouraged to submit their proposals in less than 1,000 words email@example.com. Entries close on 30 September 2018.
Click here for the complete issue.